xamoterol has been researched along with Angor Pectoris in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brasseur, LA; Buy, JJ; Decoster, PM; Detry, JM; Rousseau, MF | 1 |
| Ikäheimo, MJ; Takkunen, JT | 1 |
| Arnold, IR; Barnett, DB; Mistry, R | 1 |
| de Feyter, PJ; Serruys, PW; Suryapranata, H | 1 |
| Boström, PA; Johansson, BW; Lecerof, H; Lilja, B; Torp, A | 2 |
| Bhalla, KK; Sykes, CA; Waller, DG; Webster, J; Wray, R | 1 |
| Barrios, L; de Geest, H; Geboers, J; Piessens, JH | 1 |
5 trial(s) available for xamoterol and Angor Pectoris
| Article | Year |
|---|---|
In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Angina Pectoris; Atenolol; Double-Blind Method; Down-Regulation; Drug Tolerance; Female; Heart; Humans; Male; Middle Aged; Myocardium; Receptors, Adrenergic, beta; Xamoterol | 1993 |
Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Double-Blind Method; Exercise; Exercise Test; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic; Xamoterol | 1990 |
Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; Cardiomegaly; Cardiomyopathy, Dilated; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Ventricles; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Xamoterol | 1989 |
Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angina Pectoris; Coronary Disease; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Xamoterol | 1989 |
Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Random Allocation; Xamoterol | 1986 |
4 other study(ies) available for xamoterol and Angor Pectoris
| Article | Year |
|---|---|
Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiac Output; Coronary Disease; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Propanolamines; Pulmonary Wedge Pressure; Stimulation, Chemical; Xamoterol | 1984 |
The effects of beta 1-adrenoceptor partial agonist ICI 118.587 on left ventricular function in patients with coronary heart disease.
Topics: Adult; Angina Pectoris; Coronary Disease; Echocardiography; Electrocardiography; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Stimulation, Chemical; Xamoterol | 1984 |
Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiomyopathy, Dilated; Heart; Humans; Physical Exertion; Propanolamines; Xamoterol | 1990 |
Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiomegaly; Exercise Test; Heart Failure; Humans; Propanolamines; Xamoterol | 1989 |